Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status
Clinical trial NCT03457896 · UNKNOWN
Trial details
- NCT number
- NCT03457896
- Sponsor
- NSABP Foundation Inc
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-18
- Primary completion
- 2021-09-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.